Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion type Assertion NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_head.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion description "[Although LOH was identified at one or more markers in 22 (59%) of 37 melanoma tumors corresponding to 20 (57%) of 35 individuals, only 11 tumors from 9 individuals [9 (26%) of 35] demonstrated LOH at D9S942 and D9S1748 the markers closest to CDKN2A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_provenance.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion evidence source_evidence_literature NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_provenance.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion SIO_000772 11221846 NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_provenance.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion wasDerivedFrom befree-20140225 NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_provenance.
- NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_assertion wasGeneratedBy ECO_0000203 NP160669.RAAJ6_9-tA13mluLNjL8_xV3y1dCMteLJ-o_pkcZ2aXEg130_provenance.